Entering text into the input field will update the search result below

Edwards Lifesciences wins approval for Sapien 3 with Altera prestent

Dec. 20, 2021 10:55 AM ETEdwards Lifesciences Corporation (EW) StockBy: Jonathan Block, SA News Editor6 Comments

3d illustration of stent implantation for supporting blood circulation into blood vessels

Christoph Burgstedt/iStock via Getty Images

  • The FDA has approved the use of Edwards Lifesciences' (EW -3.0%) SAPIEN 3 transcatheter valve with the Alterra adaptive prestent for patients with severe pulmonary regurgitation.
  • The use of Alterra makes up for variations in

Recommended For You

About EW Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
EW--
Edwards Lifesciences Corporation